American Association for the Advancement of Science, Science Translational Medicine, 605(13), 2021
DOI: 10.1126/scitranslmed.abg8693
Full text: Unavailable
Selective CD47 blockade on CTLA-4 high tumor-infiltrating T reg cells reduces systemic toxicity and enhances antitumor immunity.